-
TherapeutAix to take part in Society for Medicines Research (SMR) Meeting
TherapeutAix will be taking part in the Society for Medicines Research (SMR) Meeting on “Innovative Early Clinical Trial Designs and…
-
Pitfalls with Oral Drug Administration in IPF
In the first 3 parts of our blog series on targeted delivery in idiopathic pulmonary fibrosis (IPF), we focused on the potential…
-
First-in-Human Clinical Trials
The Challenge: TherapeutAix was contacted by an innovative biotech company that was undertaking final preparations for First-in-Human clinical trials. It…
-
Asset for fibrotic disease
The Challenge: TherapeutAix was approached by a US-based biotech company to review an asset that they were considering repositioning for fibrotic…
